Skip to Content

Jardiance

In the US, Jardiance (empagliflozin systemic) is a member of the drug class SGLT-2 inhibitors and is used to treat Diabetes, Type 2.

US matches:

UK matches:

Ingredient matches for Jardiance

Empagliflozin

Empagliflozin is reported as an ingredient of Jardiance in the following countries:

  • Austria
  • Bosnia & Herzegowina
  • Croatia (Hrvatska)
  • Denmark
  • Finland
  • Germany
  • Ireland
  • Poland
  • Singapore
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide